Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kits

BackgroundEffective isolation and early treatment of coronavirus disease 2019 (COVID-19) relies on rapid, accurate, and straightforward diagnostic tools. In response to the rapidly increasing number of cases, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assays for multiple...

Full description

Bibliographic Details
Main Authors: Xuetong Zhu, Fengyan Zhou, Qi Zhou, Jiancheng Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.982171/full
_version_ 1811206267933294592
author Xuetong Zhu
Xuetong Zhu
Fengyan Zhou
Qi Zhou
Qi Zhou
Jiancheng Xu
Jiancheng Xu
author_facet Xuetong Zhu
Xuetong Zhu
Fengyan Zhou
Qi Zhou
Qi Zhou
Jiancheng Xu
Jiancheng Xu
author_sort Xuetong Zhu
collection DOAJ
description BackgroundEffective isolation and early treatment of coronavirus disease 2019 (COVID-19) relies on rapid, accurate, and straightforward diagnostic tools. In response to the rapidly increasing number of cases, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assays for multiple target genes have become widely available in the market.MethodsIn total, 236 COVID-19 patients with positive results in both RT-qPCR and rapid antigen diagnosis (Ag-RDT) were enrolled in the study. The cycle threshold (Ct) was compared with different onset times and target genes. Comparison between groups was evaluated with the Kruskal-Wallis test and Dunn test. The correlation between target genes was analyzed by Spearman.ResultsIn samples of Ct ≤ 21, Ct was different for the nucleocapsid (N), open reading frame 1ab (ORF1ab), and envelope (E) genes (P < 0.05). Mild COVID-19 patients within 7 days of onset accounted for 67.80% of all enrolled patients. At the above stage, all target genes reached the trough of Ct, and N genes showed lower values than the other target genes. The Ct of the ORF1ab and N gene in asymptomatic patients differed from those of mild patients within 7 days and more than 14 days of onset. The kits used in the study showed strong consistency among target genes, with all correlation coefficients >0.870.ConclusionRT-qPCR confirmed that the N gene performed well in Ct ≤ 21 and samples within 7 days of onset. Ag-RDT was discriminatory for patients within 7 days of onset. This study facilitated early identification and control of COVID-19 prevalence among patients.
first_indexed 2024-04-12T03:44:50Z
format Article
id doaj.art-fa138e7b084147b7847a629429f9a7eb
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-12T03:44:50Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-fa138e7b084147b7847a629429f9a7eb2022-12-22T03:49:11ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-09-011010.3389/fpubh.2022.982171982171Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kitsXuetong Zhu0Xuetong Zhu1Fengyan Zhou2Qi Zhou3Qi Zhou4Jiancheng Xu5Jiancheng Xu6Center of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, ChinaDepartment of Laboratory Medicine, The First Hospital of Jilin University, Changchun, ChinaDepartment of Infectious Disease Control, Jilin City Center for Disease Control and Prevention, Jilin, ChinaCenter of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, ChinaDepartment of Pediatrics, The First Hospital of Jilin University, Changchun, ChinaCenter of Infectious Diseases and Pathogen Biology, The First Hospital of Jilin University, Changchun, ChinaDepartment of Laboratory Medicine, The First Hospital of Jilin University, Changchun, ChinaBackgroundEffective isolation and early treatment of coronavirus disease 2019 (COVID-19) relies on rapid, accurate, and straightforward diagnostic tools. In response to the rapidly increasing number of cases, reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assays for multiple target genes have become widely available in the market.MethodsIn total, 236 COVID-19 patients with positive results in both RT-qPCR and rapid antigen diagnosis (Ag-RDT) were enrolled in the study. The cycle threshold (Ct) was compared with different onset times and target genes. Comparison between groups was evaluated with the Kruskal-Wallis test and Dunn test. The correlation between target genes was analyzed by Spearman.ResultsIn samples of Ct ≤ 21, Ct was different for the nucleocapsid (N), open reading frame 1ab (ORF1ab), and envelope (E) genes (P < 0.05). Mild COVID-19 patients within 7 days of onset accounted for 67.80% of all enrolled patients. At the above stage, all target genes reached the trough of Ct, and N genes showed lower values than the other target genes. The Ct of the ORF1ab and N gene in asymptomatic patients differed from those of mild patients within 7 days and more than 14 days of onset. The kits used in the study showed strong consistency among target genes, with all correlation coefficients >0.870.ConclusionRT-qPCR confirmed that the N gene performed well in Ct ≤ 21 and samples within 7 days of onset. Ag-RDT was discriminatory for patients within 7 days of onset. This study facilitated early identification and control of COVID-19 prevalence among patients.https://www.frontiersin.org/articles/10.3389/fpubh.2022.982171/fullcoronavirus disease 2019severe acute respiratory syndrome coronavirus 2antigen rapid diagnostic testreverse transcription-quantitative polymerase chain reactionnucleocapsid gene
spellingShingle Xuetong Zhu
Xuetong Zhu
Fengyan Zhou
Qi Zhou
Qi Zhou
Jiancheng Xu
Jiancheng Xu
Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kits
Frontiers in Public Health
coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
antigen rapid diagnostic test
reverse transcription-quantitative polymerase chain reaction
nucleocapsid gene
title Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kits
title_full Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kits
title_fullStr Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kits
title_full_unstemmed Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kits
title_short Evaluating the role of SARS-CoV-2 target genes based on two nucleic acid assay kits
title_sort evaluating the role of sars cov 2 target genes based on two nucleic acid assay kits
topic coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
antigen rapid diagnostic test
reverse transcription-quantitative polymerase chain reaction
nucleocapsid gene
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.982171/full
work_keys_str_mv AT xuetongzhu evaluatingtheroleofsarscov2targetgenesbasedontwonucleicacidassaykits
AT xuetongzhu evaluatingtheroleofsarscov2targetgenesbasedontwonucleicacidassaykits
AT fengyanzhou evaluatingtheroleofsarscov2targetgenesbasedontwonucleicacidassaykits
AT qizhou evaluatingtheroleofsarscov2targetgenesbasedontwonucleicacidassaykits
AT qizhou evaluatingtheroleofsarscov2targetgenesbasedontwonucleicacidassaykits
AT jianchengxu evaluatingtheroleofsarscov2targetgenesbasedontwonucleicacidassaykits
AT jianchengxu evaluatingtheroleofsarscov2targetgenesbasedontwonucleicacidassaykits